According to a newly published report by Persistence Market Research titled“<\/strong>Hospital Acquired Infections (HAIs) Control Market: Global Industry Analysis (2012-2016) and Forecast (2017-2025),”<\/strong>sales ofhospital acquired infections controlequipment is expected to be valued atUS$ 5,450.6 Mn<\/strong>in 2018 and this is likely to increase toUS$ 7,580.8 Mn<\/strong>in 2025, expanding at aCAGR of 4.8%<\/strong>during the study period.<\/p>\n This report tracks the performance of the global hospital acquired infections control market for a period of eight years between 2017 and 2025. A growing prevalence of hospital acquired infections across the globe, rising awareness and demand for new and improved hospital acquired infections treatment modalities, and a rapidly expanding healthcare infrastructure are some of the driving factors of the global hospital acquired infections control market.<\/p>\n Get Sample Copy of Report @https:\/\/www.persistencemarketresearch.com\/samples\/2814<\/a><\/strong><\/p>\n Company Profile<\/strong><\/p>\n Get To Know Methodology of Report @https:\/\/www.persistencemarketresearch.com\/methodology\/2814<\/a><\/strong><\/p>\n Global Hospital Acquired Infections Control Market: Restraints<\/strong><\/p>\n Global Hospital Acquired Infections Control Market: Forecast by Product Type<\/strong><\/p>\n On the basis of product type, the global hospital acquired infections control market is segmented into heat sterilization equipment, low temperature sterilization equipment, radiation sterilization equipment, and disinfection equipment.<\/p>\n In terms of revenue, disinfection equipment was the dominant product type in the global hospital acquired infections control market in 2016. In terms of growth, low temperature sterilization equipment is expected to be the fastest growing segment, registering a CAGR of 5.3% over the forecast period.<\/p>\n Access Full Report @https:\/\/www.persistencemarketresearch.com\/checkout\/2814<\/a><\/strong><\/p>\n Global Hospital Acquired Infections Control Market: Forecast by End User<\/strong><\/p>\n On the basis of end user, the global market for hospital acquired infections control is segmented into hospitals, ambulatory surgery centers, medical institutions, diagnostic laboratories and clinics.<\/p>\n Hospitals dominated the global hospital acquired infections control market in revenue terms in 2016, and the trend is projected to continue throughout the forecast period. Hospitals are expected to be the most lucrative among all end users, with a market attractiveness index of 1.6.<\/p>\n Global Hospital Acquired Infections Control Market: Forecast by Region<\/strong><\/p>\n Five regional markets namely North America, Latin America, Europe, APAC and MEA are studied in this report. North America dominated the global hospital acquired infections control market in revenue terms in 2016 and is projected to continue to do so throughout the forecast period.<\/p>\n North America is anticipated to be the most attractive regional market with an attractiveness index of 1.7 during the forecast period. Acceptance of newly developed therapeutic procedures in bacterial infections are expected to continue to provide future growth opportunities in the North America hospital acquired infections control market.<\/p>\n<\/div>\n Explore Extensive Coverage of PMR`sLife Sciences & Transformational Health<\/a>Landscape<\/strong><\/p>\n Molecular Diagnostics Market –<\/strong><\/p>\n Molecular Diagnostics Market<\/a>Segmentation by Key Players – Novartis AG, Roche Diagnostics, QIAGEN, Siemens Healthcare, Abbott Laboratories, Inc., Gen-Probe, Inc. (Hologic Inc.), Cepheid, Inc., Beckman Coulter, Inc., Becton, Dickinson & Company, Myriad Genetics, Inc., and bioMerieux.<\/p>\n Next-Generation Sequencing Market –<\/strong><\/p>\n Next Generation Sequencing Market<\/a>Segmented by(By Application – Whole-genome Sequencing ,Exome Sequencing,Targeted Resequencing,De Novo Sequencing,RNA Sequencing,ChIP Sequencing,Methyl Sequencing,Others);By Technology- Targeted Sequencing & Resequencing,Whole Genome Sequencing,Whole Exome Sequencing.<\/p>\n Ophthalmology devises Market –<\/strong><\/p>\n Ophthalmology devises Market<\/a>Segmentation by Key Players – Abbott Medical Optics Inc., Carl Zeiss Meditec AG, Bausch & Lomb Inc., Essilor International S.A, Ziemer Ophthalmic Systems AG and Topcon Corporation.<\/p>\n Intravenous Iron Drugs Market –<\/strong><\/p>\n Intravenous (IV) Iron Drugs Market<\/a>Segmentation by Key Players- Actavis, Inc., AMAG Pharmaceuticals, Inc., Galenica Ltd., Fresenius Medical Care AG & Co. KGaA, Vifor Pharma Ltd., American Regent, Inc., Luitpold Pharmaceuticals, Inc., Pharmacosmos A\/S, Rockwell Medical Technologies, Inc., and Sanofi.<\/p>\n Syndromes Progressive Ataxia Weakness Disorders Market –<\/strong><\/p>\n Treatments forSyndromes of Progressive Ataxia and Weakness Disorders Market<\/a>Segmentation by Key Players- Abbott Laboratories, Acorda Therapeutics Inc., American Regent Inc., Baxter International Inc., Biogen Idec., Bristol-Myers Squibb, Cadila Healthcare Ltd., Eli Lilly and Company, Glaxosmilthkline Plc., Sanofi, Roche Holding Ltd., Pfizer Inc. and Novartis AG.<\/p>\n About us:<\/strong><\/p>\n Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.<\/p>\n To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.<\/p>\n Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMR’s collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.<\/p>\n Contact us:<\/strong><\/p>\n 305 Broadway, 7th Floor <\/p>\n Tags: Hospital Acquired Infection Control Market Demand<\/a>, Hospital Acquired Infection Control Market Development<\/a>, Hospital Acquired Infection Control Market Revenue Share<\/a>, Hospital Acquired Infection Control Market Supply<\/a>, Hospital Acquired Infection Control Market analysis<\/a>, Hospital Acquired Infection Control Market forecast<\/a>, Hospital Acquired Infection Control Market growth<\/a>, Hospital-Acquired Infection Control Market Size<\/a>, Hospital-Acquired Infection Control Market Trends<\/a><\/p>\n 305 Broadway, 7th Floor Tags:<\/b> 305 Broadway, 7th Floor![\"hospital](\"https:\/\/www.persistencemarketresearch.com\/images\/hospital-acquired-infections-control-market.jpg\" "\\"Hospital")
<\/p>\n\n
\n
\nNew York City, NY 10007
\nUnited States
\nPh.no. +1-646-568-7751
\nE-mail id-sales@persistencemarketresearch.com<\/a>
\nWebsite:https:\/\/www.persistencemarketresearch.com<\/a><\/p>\n<\/div>\n
Contact Information:<\/b><\/p>\n
New York City, NY 10007
United States
Ph.no.<\/strong> +1-646-568-7751
E-mail id- sales@persistencemarketresearch.com<\/a><\/strong>
Website: https:\/\/www.persistencemarketresearch.com<\/a><\/strong><\/p>\n
<\/a>, Extended Distribution<\/a>, Research Newswire<\/a>, English<\/a><\/p>\n<\/div>\n
Contact Information:<\/h3>\n
New York City, NY 10007
United States
Ph.no.<\/strong> +1-646-568-7751
E-mail id- sales@persistencemarketresearch.com<\/a><\/strong>
Website: https:\/\/www.persistencemarketresearch.com<\/a><\/strong><\/p>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"![\"\"](\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2020\/05\/4027-1588609253.png\")
According to a newly published report by Persistence Market Research titled “Hospital Acquired Infections (HAIs) Control Market: Global Industry Analysis (2012-2016) and Forecast (2017-2025),” sales of hospital acquired infections control equipment is expected to be valued at US$ 5,450.6 Mn in 2018 and this is likely to increase to US$ 7,580.8 Mn in 2025, expanding at a CAGR of 4.8% during the study period. This … Continue reading Sales Revenue in the Hospital Acquired Infection Control Market to Witness Growth at Robust CAGR 4.5% During 2025<\/span><\/a> Continue Reading
<\/p>\n